Fixed-duration glofitamab monotherapy continues to demonstrate durable responses in patients with relapsed or refractory large B-cell lymphoma: 3-year follow-up from a pivotal phase II study Meeting Abstract
| Authors: | Dickinson, M. J.; Carlo-Stella, C.; Morschhauser, F.; Bachy, E.; Cartron, G.; Corradini, P.; Bartlett, N. L.; Iacoboni, G.; Khan, C.; Hertzberg, M. S.; Falchi, L.; Brody, J.; Trněný, M.; Mulvihill, E.; Berthier, A.; Bottos, A.; Relf, J.; Tchaleu, F. B.; Lundberg, L.; Hutchings, M. |
| Abstract Title: | Fixed-duration glofitamab monotherapy continues to demonstrate durable responses in patients with relapsed or refractory large B-cell lymphoma: 3-year follow-up from a pivotal phase II study |
| Meeting Title: | 66th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 144 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Dec 7-10 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-11-05 |
| Start Page: | 865 |
| End Page: | 867 |
| Language: | English |
| ACCESSION: | WOS:001412804100009 |
| DOI: | 10.1182/blood-2024-194333 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
